Cargando…

Remote tissue immune priming in allergic disease

Detalles Bibliográficos
Autor principal:	Ubags, Niki D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434592/ https://www.ncbi.nlm.nih.gov/pubmed/32719410 http://dx.doi.org/10.1038/s41385-020-0328-0

Ejemplares similares

Apoptotic mitochondria prime anti-tumour immunity
por: McArthur, Kate, et al.
Publicado: (2020)

Secured remote health monitoring system
por: Sathya, Duraisamy, et al.
Publicado: (2017)

Emerging mechanisms and novel targets in allergic inflammation and asthma
por: Weiss, Scott T.
Publicado: (2017)

Awake prone positioning in COVID-19: is tummy time ready for prime time?
por: Weatherald, Jason, et al.
Publicado: (2021)

Allergic Disease with Selective IgA Deficiency. Comment on Cinicola et al. The Allergic Phenotype of Children and Adolescents with Selective IgA Deficiency: A Longitudinal Monocentric Study. J. Clin. Med. 2022, 11, 5705
por: Özdemir, Öner
Publicado: (2023)

Resilience-by-Design and Resilience-by-Intervention in supply chains for remote and indigenous communities
por: Mahoney, Emerson, et al.
Publicado: (2022)

Need for clarifying remote physiologic monitoring reimbursement during the COVID-19 pandemic: a respiratory disease case study
por: Jarrin, Robert, et al.
Publicado: (2021)

Remote monitoring and digital health tools in CVD management
por: Cowie, Martin R., et al.
Publicado: (2021)

Primary hyperoxaluria type 1: time for prime time?
por: Bacchetta, Justine, et al.
Publicado: (2022)

IBD in the time of corona — vigilance for immune-mediated diseases
por: Moschen, Alexander R.
Publicado: (2020)

Milder disease with Omicron: is it the virus or the pre-existing immunity?
por: Sigal, Alex
Publicado: (2022)

Monkeypox infection creates immune signatures of disease progression
por: Kennedy, Rick B
Publicado: (2023)

Allergic rhinitis and association with the O blood group
por: Carpeggiani, Clara
Publicado: (2011)

COVID-19 vaccination in patients with immunity-mediated kidney disease
por: Prendecki, Maria, et al.
Publicado: (2021)

Effectiveness of COVID-19 vaccination in immune-mediated inflammatory diseases
por: Sparks, Jeffrey A, et al.
Publicado: (2022)

Omicron breakthrough infections in patients with immune-mediated inflammatory diseases
por: Liew, Jean W, et al.
Publicado: (2022)

Hybrid immunity versus vaccine-induced immunity against SARS-CoV-2 in patients with autoimmune rheumatic diseases
por: Shenoy, Padmanabha, et al.
Publicado: (2022)

Early life immunity in the era of systems biology: understanding development and disease
por: Schaffert, Steven, et al.
Publicado: (2018)

Role of immunity landscape in global risk assessment of re-emerging diseases
por: Pandey, Abhishek, et al.
Publicado: (2023)

The case for increasing diversity in tissue-based functional genomics datasets to understand human disease susceptibility
por: Long, Erping, et al.
Publicado: (2022)

Remote Allergen Exposure Elicits Eosinophil Infiltration into Allergen Non-Exposed Mucosal Organs and Primes for Allergic Inflammation
por: Olbrich, Courtney L., et al.
Publicado: (2020)

Conceptual model of Remotely Accessed Mobile Application for Psychiatric disorder Screening (RoAdMAPS): a self-screening and referral aid for mental health in India
por: Agarwal, Aditya, et al.
Publicado: (2022)

Dromedary MERS-CoV replicates in human respiratory tissues
por: Reperant, Leslie A, et al.
Publicado: (2014)

COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases
por: Boekel, Laura, et al.
Publicado: (2022)

Comment on Viderman et al. Remote Monitoring of Chronic Critically Ill Patients after Hospital Discharge: A Systematic Review. J. Clin. Med. 2022, 11, 1010
por: Farahani, Parisa, et al.
Publicado: (2023)

Towards brain-tissue-like biomaterials
por: Axpe, Eneko, et al.
Publicado: (2020)

Tissue transglutaminase in the pathogenesis of heart failure
por: Shinde, Arti V., et al.
Publicado: (2017)

Big bottlenecks in cardiovascular tissue engineering
por: Huang, Ngan F., et al.
Publicado: (2018)

Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease
por: Haberman, Rebecca H, et al.
Publicado: (2022)

SARS-CoV-2: from herd immunity to hybrid immunity
por: Goldblatt, David
Publicado: (2022)

Immunity and the coral crisis
por: Palmer, Caroline V.
Publicado: (2018)

Somatic mutation and clonal expansions in human tissues
por: Martincorena, Inigo
Publicado: (2019)

Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease
por: Gao, Xing-Su, et al.
Publicado: (2022)

SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period
por: Boekel, Laura, et al.
Publicado: (2022)

Scaling the immune incline in PDAC
por: Rojas, Luis A., et al.
Publicado: (2021)

COVID-19 and risk management in a tissue bank
por: Paggiaro, André Oliveira, et al.
Publicado: (2020)

Can we conclude a potential therapeutic action for Parkinson’s disease by using postmortem tissue and a preclinical model based on an exogenous neurotoxin?
por: Segura-Aguilar, Juan
Publicado: (2018)

Remote magnetic catheter navigation: more than just bells and whistles ?
por: de Groot, N. M. S.
Publicado: (2013)

Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases
por: Goulenok, Tiphaine, et al.
Publicado: (2022)

Protective immunity after recovery from SARS-CoV-2 infection
por: Kojima, Noah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2o976006sta94t4nso0941d98o